2016年经血管途径经导管主动脉瓣植入术后的结局
该研究基于德国强制性质量登记数据,分析2014至2016年所有经血管途径经导管主动脉瓣植入术(TV-TAVI)与孤立性外科主动脉瓣置换术(iSAVR)的手术量、并发症及院内死亡率。2016年TV-TAVI院内死亡率为2.6%,首次在数值上低于iSAVR的2.9%(P=0.19);分层分析显示,在高危、极高危和中危组中TV-TAVI院内死亡率显著低于iSAVR,低危组两者相似。
要点
- 2016年TV-TAVI院内死亡率为2.6%,iSAVR为2.9%,差异无统计学意义(P=0.19)。
- 极高危、高危和中危组TV-TAVI院内死亡率显著低于iSAVR。
- 低危组TV-TAVI与iSAVR院内死亡率相似(1.6% vs 1.4%,P=0.4)。
核心结论
- 2016年TV-TAVI总体院内死亡率首次在数值上低于iSAVR。
- 低危组院内死亡率与iSAVR相似,其他风险组TV-TAVI显著更低。
研究设计与样本
- 基于德国强制性质量登记项目,分析2014至2016年所有经血管途径经导管主动脉瓣植入术(TV-TAVI)与孤立性外科主动脉瓣置换术(iSAVR)患者。
- 2016年德国TV-TAVI手术量超过15 000例。
主要发现
- 2016年TV-TAVI总体院内死亡率为2.6%,iSAVR为2.9%(P=0.19)。
- 术后新起搏器植入率2015年为12.6%,2016年为11.4%(P=0.002)。
- 血管并发症发生率2015年为8.5%,2016年为7.1%(P<0.001)。
- 按德国主动脉瓣评分分层,TV-TAVI观察/预期院内死亡率比(O/E)为0.68。
- 极高危组TV-TAVI与iSAVR院内死亡率分别为11.3%与23.6%(P<0.001),高危组为4.1%与9.2%(P<0.001),中危组为3.0%与4.6%(P=0.016),低危组为1.6%与1.4%(P=0.4)。
临床怎么用
- 在高危、极高危和中危主动脉瓣病变患者中,TV-TAVI的院内死亡率显著低于iSAVR。
- 低危患者中TV-TAVI与iSAVR院内死亡率相似,选择术式需综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: We analysed the number of procedures, complications, and in-hospital mortality rates of all patients undergoing transvascular transcatheter aortic valve implantation (TV-TAVI) in comparison to isolated surgical aortic valve replacement (iSAVR) from 2014 to 2016 in Germany. METHODS AND RESULTS: All aortic valve procedures performed in Germany are mandatorily registered in a quality control program. More than 15 000 TV-TAVI procedures were performed in 2016 in Germany. Especially the number of post-procedural complications declined within the last few years, including new pacemaker implantations (2015: 12.6% vs. 2016: 11.4%, P = 0.002) and vascular complications (2015: 8.5% vs. 2016: 7.1%; P < 0.001). Thus, in 2016 the overall in-hospital mortality rate after TV-TAVI was 2.6%, which is for the first time numerically below that of iSAVR, which was 2.9% (P = 0.19). A stratified analysis according to the German aortic valve score shows a lower observed than expected in-hospital mortality rate for TV-TAVI (O/E 0.68). Additionally, the in-hospital mortality was significantly lower after TV-TAVI than after iSAVR in the very high- (11.3% vs. 23.6%; P < 0.001), in the high- (4.1% vs. 9.2%; P < 0.001), and in the intermediate-risk group (3.0% vs. 4.6%; P = 0.016) and was similar to that of iSAVR in low-risk patients (1.6% vs. 1.4%; P = 0.4). CONCLUSION: The overall in-hospital mortality after TV-TAVI was numerically lower than after iSAVR in 2016 for the first time. In the low risk group in-hospital mortality was similar, whereas in all other risk groups in-hospital mortality after TV-TAVI was significantly lower than after SAVR. This is likely to contribute to a redefinition of the standard of care in the future.
引用
- Gaede L, Blumenstein J, Liebetrau C, et al. Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J. 2018. PMID: 29228149. doi:10.1093/eurheartj/ehx688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。